AZ@GAME-Eco: Economic Assessment of Serious Games for the Management of Alzheimer's Disease and R… (NCT03208491) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
AZ@GAME-Eco: Economic Assessment of Serious Games for the Management of Alzheimer's Disease and Related Disorders
France136 participantsStarted 2017-09-30
Plain-language summary
The main objective of AZ@GAME ECO is to evaluate the cost-utility of the management of patients suffering from Alzheimer's disease using a serious game providing cognitive and physical straining compared to a usual management. Among the secondary objectives it is important to assess the real life feasibility in different types of care structures.
Who can participate
Age range
60 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Male or Female ≥ 60 years of age;
* Subjects diagnosed with Alzheimer's Disease or related disorders associated with mild to moderately severe (CIM 10)
* a score between 12 and 24 on the Mini Mental score evaluation
* Subject treated in one of the participating centers
* To have the social welfare insurance
* Signature of the free and informed consent in the case of a patient under guardianship with signature of the guardian
Exclusion Criteria:
* history of epilepsy
* major walking or balance disorder.
* Subject without freedom by judicial or administrative decision
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial is studying whether a 'serious game' approach is cost-effective for managing Alzheimer's disease — can you explain what these serious games actually involve, and whether something like this might be appropriate to discuss for my situation?
2Since this study is measuring a 'cost utility ratio' as its main outcome, it sounds like it's focused on economic value rather than directly testing whether the treatment works — does that mean the clinical effectiveness has already been established separately, and what does that mean for what we'd learn from this study?
3The trial is listed as 'active but not recruiting,' which means they're no longer enrolling new participants — are there similar studies or programs involving digital or game-based therapies for Alzheimer's that are currently open and that might be worth looking into?
4This trial doesn't have a traditional phase listed, which suggests it may not be a standard drug or device trial — how does that affect what we know about the safety and risks of participating in a game-based intervention like this compared to a conventional treatment study?
5Are there any standard care options or other non-drug approaches for Alzheimer's management that we should consider alongside or before looking into game-based therapies like the ones being studied in this trial?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.